Insider at Medical Device Maker Buys More Than 7,500 Shares

Key Points The acquisition involved 7,598 shares at a weighted average price of $19.74 per share, representing a total investment of ~$150,000. The transaction size equals 14% of the equity stake held by the executive before the filing. This purchase increased total direct holdings to 61,238 shares, with no reported indirect ownership. The capital commitment occurred following a -37% one-year total return for the stock as of the September 3, 2026 transaction date. 10 stocks we like better than Enovis › Oliver Engert, Chief Administrative Officer of Enovis Corporation (NYSE:ENOV) , executed a direct purchase of 7,598 shares of common stock in transactions on Sept. 2, 2026, and Sept. 3, 2026, according to a recent SEC Form 4 filing .